Digoxin Antikörper
-
- Target Alle Digoxin (DIG) Produkte
- Digoxin (DIG)
- Reaktivität
- Bitte anfragen
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Digoxin Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität (Details)
- Digoxin
- Aufreinigung
- Purified by Protein G.
- Immunogen
- Digoxin-BSA
- Klon
- 2E2
- Isotyp
- IgG
-
-
- Applikationshinweise
-
IHC-P 1:200-400
IF(IHC-P) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- Digoxin (DIG)
- Andere Bezeichnung
- Digoxin (DIG Produkte)
- Substanzklasse
- Chemical
- Hintergrund
-
Synonyms: Lanoxin.
Background: Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat).
-